These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16554161)

  • 21. Design, synthesis, and antiproliferative activity of some novel aminosubstituted xanthenones, able to overcome multidrug resistance toward MES-SA/Dx5 cells.
    Kostakis IK; Tenta R; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H; Kletsas D
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5057-60. PubMed ID: 16169719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
    Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
    Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A subset of highly effective propafenone-type multidrug resistance modulators lacks effects on cardiac action potential and mechanical twitch parameters of rat papillary muscles.
    Schmid D; Staudacher DL; Loew HG; Spieckermann PG; Ecker GF; Kopp S; Chiba P
    J Pharmacol Exp Ther; 2003 Nov; 307(2):589-96. PubMed ID: 12966158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lathyrane diterpenes from Euphorbia lathyris as modulators of multidrug resistance and their crystal structures.
    Jiao W; Dong W; Li Z; Deng M; Lu R
    Bioorg Med Chem; 2009 Jul; 17(13):4786-92. PubMed ID: 19443229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological evaluation, structure-activity relationships, and three-dimensional quantitative structure-activity relationship studies of dihydro-beta-agarofuran sesquiterpenes as modulators of P-glycoprotein-dependent multidrug resistance.
    Reyes CP; Muñoz-Martínez F; Torrecillas IR; Mendoza CR; Gamarro F; Bazzocchi IL; Núñez MJ; Pardo L; Castanys S; Campillo M; Jiménez IA
    J Med Chem; 2007 Oct; 50(20):4808-17. PubMed ID: 17850057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance.
    Ecker G; Chiba P; Hitzler M; Schmid D; Visser K; Cordes HP; Csöllei J; Seydel JK; Schaper KJ
    J Med Chem; 1996 Nov; 39(24):4767-74. PubMed ID: 8941391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cis-6-oxo-hexahydro-2-oxa-1,4-diazapentalene and cis-6-oxo-hexahydropyrrolo[3,2-c]pyrazole based scaffolds: design rationale, synthesis and cysteinyl proteinase inhibition.
    Wang Y; Benn A; Flinn N; Monk T; Ramjee M; Watts J; Quibell M
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1327-31. PubMed ID: 15713380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramolecular distribution of hydrophobicity influences pharmacological activity of propafenone-type MDR modulators.
    Pleban K; Hoffer C; Kopp S; Peer M; Chiba P; Ecker GF
    Arch Pharm (Weinheim); 2004 Jun; 337(6):328-34. PubMed ID: 15188222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCASE study of the multidrug resistance reversal activity of propafenone analogs.
    Klopman G; Zhu H; Ecker G; Chiba P
    J Comput Aided Mol Des; 2003; 17(5-6):291-7. PubMed ID: 14635722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors.
    Lin R; Chiu G; Yu Y; Connolly PJ; Li S; Lu Y; Adams M; Fuentes-Pesquera AR; Emanuel SL; Greenberger LM
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4557-61. PubMed ID: 17574416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression.
    Zheng LH; Bao YL; Wu Y; Yu CL; Meng X; Li YX
    Cancer Lett; 2008 Dec; 272(1):102-9. PubMed ID: 18703276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
    Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships.
    Camacho ME; León J; Entrena A; Velasco G; Carrión MD; Escames G; Vivó A; Acuña-Castroviejo D; Gallo MA; Espinosa A
    J Med Chem; 2004 Nov; 47(23):5641-50. PubMed ID: 15509163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
    Kars MD; Işeri OD; Gunduz U; Molnar J
    Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of multidrug resistance by 4-chloro-N-(3-((E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl)phenyl)benzamide through the reversible inhibition of P-glycoprotein.
    Kim YK; Song YJ; Seo DW; Kang DW; Lee HY; Rhee DK; Han JW; Ahn CM; Lee S; Kim SN
    Biochem Biophys Res Commun; 2007 Mar; 355(1):136-42. PubMed ID: 17286965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydropyridines and atypical MDR: a novel perspective of designing general reversal agents for both typical and atypical MDR.
    Miri R; Mehdipour A
    Bioorg Med Chem; 2008 Sep; 16(18):8329-34. PubMed ID: 18701304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.